AstraZeneca
oncology and total revenue in fueled by strong global demand growth oncology key dynamics continued and global demand growth short term impact from anti corruption campaign in demand growth slightly offset by label restriction decreased use in the us continued strong global launch momentum preferred across and penetration in and new global launches uptake us new indications regulatory update us priority review submission acceptance | AstraZeneca
Company
Deck Type
Deck date
November 2023
Slide
15 of 45
Similar slides by AstraZeneca
Results
July 2023
Results
April 2023
Results
February 2023
Related slides by other companies
Investor Conference
September 2023
Investor Conference
August 2022
Results
February 2024
Investor Presentation
December 2023
Other recent decks by AstraZeneca
Results
February 2024
Investor Conference
January 2024
Results
July 2023
Investor Event
June 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io